Abstract:Background: P38α is a ubiquitous protein kinase, which plays diverse roles in cancers. Surprisingly, P38α functions vary markedly in different cancers (e.g., cancer suppressor vs cancer promoter). However, there is no report on the expression of P38α, the family's most important member, in pancreatic ductal adenocarcinoma (PDAC) and its association with clinicoathological parameters and patients' prognosis. Materials and methods: We retrospectively analyzed 152 patients who underwent surgery and were pathologically diagnosed with PDAC from September 2013 to September 2015. We used immunohistochemistry to detect P38α expression in tumor and adjacent normal tissues. The significance of the association between P38α and clinicopathological parameters was evaluated using the χ² test and t tests. The Kaplan-Meier method was used to assess the association between P38α expression and preoperative carbohydrate antigen 19-9 (CA19-9) levels and patients' overall survival. The Cox regression model was used to analyze the association between clinicopathological parameters, P38α and preoperative CA19-9 levels, and prognosis. Statistical significance was defined as P < 0.05. Results: P38α was expressed in 63.16% tumor tissues of PDAC, which was significantly higher compared with the adjacent normal tissues (26.32%, P < 0.001). High expression of P38α was associated with patients' histological grade (P = 0.013), lymphatic metastasis (P = 0.025) and TNM stage (P = 0.048). The median survival time of the P38α-high group was 9.2 months, which was shorter compared with that of the P38α-low group (17.3 months, P = 0.011). The median survival time of the CA19-9 > 43.63 group was 11.1 months shorter than that of the CA19-9 < 43.63 group (24.8 months, P < 0.001). The Cox regression model revealed that age (P = 0.003), lymphatic invasion (P = 0.015), TNM stage (P = 0.003), histological grade (P < 0.001), preoperative CA19-9 (P = 0.049), and P38α expression (P = 0.008) were statistically significant independent risk factors affecting prognosis. Specifically, overall survival was 28.4 months in the P38α-low and CA19-9 < 43.63 groups, 16.3 months in the P38α-high or CA19-9 > 43.63 groups, and 9.7 months in the P38α-high and CA19-9 > 43.63 groups (P < 0.001). Conclusions: High expression of P38α was significantly associated with histological grade, lymphatic metastasis, TNM stage and prognosis in patients with PDAC. P38α and preoperative CA19-9 levels were independent risk factors affecting the prognosis of PDAC patients. High expression of p38α and preoperative carbohydrate antigen 19-9 indicate poor prognosis in patients with PDAC.

AQP1 and AQP3 Expression Are Associated with Severe Symptoms and Poor-prognosis of the Pancreatic Ductal Adenocarcinoma.

The Expression of Aquaporin-1 and Aquaporin-3 in Extrahepatic Cholangiocarcinoma and Their Clinicopathological Significance.

AQP5 Is a Novel Prognostic Biomarker in Pancreatic Adenocarcinoma

[Significance of Aquaporin-1 and Aquaporin-3 Expression in Colorectal Carcinoma].

Identification of Spindle and Kinetochore-Associated Family Genes As Therapeutic Targets and Prognostic Biomarkers in Pancreas Ductal Adenocarcinoma Microenvironment

Glypican-3 and Krt19 Are Markers Associating with Metastasis and Poor Prognosis of Pancreatic Ductal Adenocarcinoma

Expression of Aquaporin 1, 3 and 5 in Colorectal Carcinoma: Correlation with Clinicopathological Characteristics and Prognosis.

[Cytoplasmic Expression of Aquaporin-1 in Breast Cancer Cells and Its Relationship with Clinicopathological Characteristics and Prognosis].

Abnormal expression and the significant prognostic value of aquaporins in clear cell renal cell carcinoma

Comprehensive Exploration of the Expression and Prognostic Value of AQPs in Clear Cell Renal Cell Carcinoma

Elevated AQP1 Expression is Associated with Unfavorable Oncologic Outcome in Patients with Hilar Cholangiocarcinoma.

Significant Prognostic Values of Aquaporin Mrna Expression in Breast Cancer

Aquaporins Transcripts with Potential Prognostic Value in Pancreatic Cancer

The Expression of Aquaporin-1 and Aquaporin-5 in Epithelial Ovarian Tumors and Its Clinic Signifiance.

Expression of astrocyte elevated gene-1 (AEG-1) as a biomarker for aggressive pancreatic ductal adenocarcinoma

High Expression of P38α and Preoperative Carbohydrate Antigen 19-9 Indicate Poor Prognosis in Patients with Pancreatic Ductal Adenocarcinoma

Expression of AQP3 and AQP5 As a Prognostic Marker in Triple-Negative Breast Cancer.

The Association Between Aquaporin-1 Expression, Microvessel Density and the Clinicopathological Features of Hepatocellular Carcinoma.

Expression and Role of AQP1 in Cervical Squamous Carcinoma and Its Precancerous Lesions

Comprehensive Analysis of Aquaporin Superfamily in Lung Adenocarcinoma

The PD-L1 Expression and Tumor-Infiltrating Immune Cells Predict an Unfavorable Prognosis in Pancreatic Ductal Adenocarcinoma and Adenosquamous Carcinoma.